| 
Results for rilonacept. Search took 0.14 seconds.
Arcalyst: New Orphan Drug FDA-Approved for Treatment of Rare Inflammatory Syndromes
in Straightfromthedoc, on February 28, 2008
...an extremely rare condition known as Cryopyrin-Associated Periodic Syndrome or CAPS .
Arcalyst ( rilonacept, an Interleukin-1 blocker ) is now approved for the long term treatment of two Cryopyrin-...